Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml.
Phase of Trial: Phase II
Latest Information Update: 01 May 2015
At a glance
- Drugs Maraviroc (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Proof of concept; Therapeutic Use
- Acronyms VEMAN
- 06 Mar 2013 Interim results reporting changes in CD4 cells and CD4 subsets presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 28 Jul 2011 New trial record